Gain or Pain—Automating the OTC and Structured Products Markets

The electronification of front-office trading functions around equities and vanilla fixed income products is now largely complete across the global capital markets. Next on the agenda for capital markets firms are their over-the-counter (OTC) and structured products businesses, which—while the notion of automating these asset classes might make the most battle-hardened market participants wince—nonetheless offer enticing business and operational benefits.

This white paper, based on a survey carried out by WatersTechnology in collaboration with Numerix, explores the increased demand from firms looking to automate the front-office processes around their OTC and structured products businesses.

It further examines the technology, operational and business-case challenges they must consider when embarking on such projects and the tangible business benefits they stand to glean on the back of more systematized and efficient front-office processes supporting these exotic instruments.